HOME >> BIOLOGY >> NEWS
New MUHC study adds more evidence to clear measles mumps rubella vaccine as a risk factor for autism

A new MUHC study provides conclusive evidence that the Measles Mumps Rubella (MMR) vaccine is not associated with the development of autism spectrum disorders (ASDs). The study, published in the scientific journal Pediatrics, reveals fundamental errors in previous molecular studies that falsely implicated the MMR vaccine as a risk factor for autism. This study arose from a cross-disciplinary collaboration between Dr Brian Ward, Chief of Infectious Diseases at the MUHC, and Dr Eric Fombonne, Director of Pediatric Psychiatry at the Montreal Children's Hospital of the MUHC

"The hypothesis linking the MMR vaccine to autism was initially supported by molecular studies that found the measles virus persisting in certain biological tissues of children with autism who had received the MMR vaccination," says Dr. Eric Fombonne. Yasmin D'Souza, a graduate student in Dr. Ward's laboratory, used a carefully-structured approach to uncover errors in the techniques that had been used in these earlier studies which led to the false identification of the measles virus.

"The reluctance of parents to inoculate their children due to widespread fear of the MMR vaccine generated by these early studies has resulted in measles outbreaks, likely contributing to the deaths of several infants in the United Kingdom," says Dr. Brian Ward. "We hope that our investigation of these earlier studies will finally clear the MMR vaccine of its link to autism and give parents confidence in their choice to accept vaccination their children against this potentially fatal disease."

The biological evidence from this new MUHC study correlates with the epidemiological evidence from another previous MUHC study that also proves that the MMR vaccine has no link to autism. The previous study, led by Dr. Fombonne, was published in the July 5 issue of Pediatrics. All well-conducted epidemiological studies have found no association between the MMR vaccine and autism at the population leve
'"/>

Contact: Ian Popple
ian.popple@muhc.mcgill.ca
514-843-1560
McGill University
17-Oct-2006


Page: 1 2

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. Multicenter study nets new lung tumor-suppressor gene
9. MIT study: Maturity brings richer memories
10. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
11. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... GREEN, Ohio (PRWEB) , ... ... ... Engineered Products , a global leader in the design and manufacturer of ... selection of seating and adjustable footrests compliant with Healthier Hospital Initiative guidelines. ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... microbial identification, played a key role in the award-winning study “Next Generation Sequencing ... Rothman Institute. The molecular diagnostic laboratory processed samples using Next Generation DNA Sequencing ...
(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... ... that Donald Stanski, MD, a senior pharmaceutical industry executive with expertise in clinical ... simulation for drug and disease strategic data analytics, has joined the firm as ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare , ... for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information from ... 2.0 will give urologists across Europe the ability to perform targeted transrectal and ...
(Date:11/2/2019)... NEW YORK (PRWEB) , ... October 31, 2019 ... ... just been released by pharma artificial intelligence pioneer tellic. drug360 brings tellic’s ... data. This new tool allows researchers to quickly uncover relationships between genes, diseases, ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality Solutions, ... sponsorship and cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, ... California. , The Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge ...
(Date:10/22/2019)... N.J. (PRWEB) , ... October 22, 2019 , ... Catalent, ... Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session ... Conference (HPCLC), to be held at the Gwen Hotel, Chicago, on Oct. 28-30, 2019. ...
Breaking Biology Technology:
Cached News: